LEVOLET Drug Patent Profile
✉ Email this page to a colleague
When do Levolet patents expire, and when can generic versions of Levolet launch?
Levolet is a drug marketed by Genus Lifesciences and is included in one NDA. There are two patents protecting this drug.
The generic ingredient in LEVOLET is levothyroxine sodium. There are ten drug master file entries for this compound. Fifty-one suppliers are listed for this compound. Additional details are available on the levothyroxine sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Levolet
A generic version of LEVOLET was approved as levothyroxine sodium by MYLAN on June 5th, 2002.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for LEVOLET?
- What are the global sales for LEVOLET?
- What is Average Wholesale Price for LEVOLET?
Summary for LEVOLET
| US Patents: | 2 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 77 |
| Clinical Trials: | 2 |
| Patent Applications: | 2,565 |
| DailyMed Link: | LEVOLET at DailyMed |
Recent Clinical Trials for LEVOLET
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Dr. Reddy's Laboratories Limited | Phase 4 |
| Dr. Reddy's Laboratories Limited |
US Patents and Regulatory Information for LEVOLET
LEVOLET is protected by two US patents.
Patents protecting LEVOLET
Thyroid hormone oral dosage forms and methods of using the same
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Thyroid hormone oral dosage forms and methods of using the same
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genus Lifesciences | LEVOLET | levothyroxine sodium | TABLET;ORAL | 021137-001 | Jun 6, 2003 | AB1,AB2,AB3,AB4 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Genus Lifesciences | LEVOLET | levothyroxine sodium | TABLET;ORAL | 021137-010 | Jun 6, 2003 | AB1,AB2,AB3,AB4 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||
| Genus Lifesciences | LEVOLET | levothyroxine sodium | TABLET;ORAL | 021137-005 | Jun 6, 2003 | AB1,AB2,AB3,AB4 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||
| Genus Lifesciences | LEVOLET | levothyroxine sodium | TABLET;ORAL | 021137-003 | Jun 6, 2003 | AB1,AB2,AB3,AB4 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||
| Genus Lifesciences | LEVOLET | levothyroxine sodium | TABLET;ORAL | 021137-007 | Jun 6, 2003 | AB1,AB2,AB3,AB4 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
